Dexcom (DXCM) Change in Inventory (2010 - 2026)

Dexcom (DXCM) has reported Change in Inventory for 17 consecutive years, with $36.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Inventory rose 96.76% year-over-year to $36.4 million in Q2 2026; TTM through Jun 2026 was $153.0 million, a 927.03% increase from a year earlier, with the FY2025 full-year figure at $63.7 million, up 613.71% from the prior year.
• Change in Inventory was $36.4 million for Q2 2026 at Dexcom, down from $65.2 million in the prior quarter.
• Over five years, Change in Inventory peaked at $78.6 million in Q3 2023 and troughed at -$32.7 million in Q4 2024.
• A 5-year average of $19.8 million and a median of $18.2 million in 2025 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory tumbled 223.96% in 2022 and jumped 5136.36% in 2023, its largest moves.
• Over 5 years, Change in Inventory stood at -$5.7 million in 2022, then surged by 1135.09% to $59.0 million in 2023, then slumped by 155.42% to -$32.7 million in 2024, then soared by 154.43% to $17.8 million in 2025, then jumped by 104.49% to $36.4 million in 2026.
• The last three Change in Inventory figures came in at $36.4 million (Q2 2026), $65.2 million (Q1 2026), and $17.8 million (Q4 2025), per Business Quant data.